Radiologists interpreting scans of patients with suspected pulmonary embolism should check for signs of right heart dysfunction. This action could save a patient’s life, according to a study presented at the American Roentgen Ray Society meeting in May.
Radiologists interpreting scans of patients with suspected pulmonary embolism should check for signs of right heart dysfunction. This action could save a patient's life, according to a study presented at the American Roentgen Ray Society meeting in May.
Patients with PE often die due to acute right heart failure, said lead author Dr. Benjamin Zalta. Patients with PE and right valve dilation have increased mortality rates.
"CT can be diagnostic of pulmonary embolism and also has prognostic implications," Zalta said.
Zalta and colleagues at Albert Einstein College of Medicine and the Montefiore Medical Center in New York City retrospectively examined 74 consecutive adults who had been diagnosed with PE on either a four- or 16-slice CT scanner. Thirty-four had received echocardiography as well.
The researchers diagnosed right heart dysfunction in patients with dilated right ventricles or an interventricular septum that flattened or bowed into the left ventricle. They also determined clot burden.
Sixty-six percent of patients had CT findings of right heart dysfunction, while nearly 50% had clot burdens greater than or equal to 30% pulmonary vascular obstruction.
CT showed a significant difference between the mean clot burden in patients with right heart dysfunction (49) and those without (25). Echocardiography showed no such significant difference.
Sensitivity and specificity for CT were 81% and 47%, respectively, compared with echocardiography's 56% and 42%. Four echo studies did not provide adequate images.
For more information from the online Diagnostic Imaging archives:
Negative CT scan rules out pulmonary embolism
CTA nails down role of gold standard for pulmonary embolism
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AMA Approves Category III CPT Codes for AI-Enabled Perivascular Fat Analysis from CT Scans
April 9th 2025Going into effect in 2026, the new CPT codes may facilitate increased adoption of the CaRi-Heart software for detecting coronary inflammation from computed tomography scans pending FDA clearance of the technology.
FDA Clears AI Assessment of Ischemic Core Volume on CT with Brainomix 360 Platform
April 8th 2025For patients with acute ischemic stroke, research has demonstrated that automated assessment of ischemic core volume on brain CT scans via the Brainomix 360 software is equivalent to that derived from CT perfusion.